|
|
???tair.name??? >
???browser.page.title.author???
|
"yang ss"???jsp.browse.items-by-author.description???
Showing items 11-20 of 68 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
| 中山醫學大學 |
2021 |
The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
|
Lee, SW; Lee, TY; Cheng, YC; Yen, CL; Yang, SS |
| 中山醫學大學 |
2021 |
Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor
|
Liao, TL; Chen, YM; Hsieh, SL; Tang, KT; Chen, DY; Yang, YY; Liu, HJ; Yang, SS |
| 中山醫學大學 |
2021 |
Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease
|
Tsai, HJ; Chuang, YW; Yang, SS; Chang, YZ; Chang, HR; Lee, TY |
| 中山醫學大學 |
2021 |
Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation
|
Lai, CY; Yang, SS; Lee, SW; Tsai, HJ; Lee, TY |
| 中山醫學大學 |
2021 |
Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Chen, CY; Su, WW; Tseng, KC; Lo, CC; Liu, CJ; Chen, JJ; Peng, CY; Shih, YL; Yang, SS; Huang, CS; Huang, KJ; Chang, CY; Tsai, MC; Kao, WY; Fang, YJ; Chen, PY; Su, PY; Tseng, CW; Huang, JJ; Lee, PL; Lai, HC; Hsieh, TY; Chang, CH; Huang, YJ; Lee, FJ; Chang, CC; Kao, JH |
| 中山醫學大學 |
2021 |
Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan
|
Cheng, PN; Mo, LR; Chen, CT; Chen, CY; Huang, CF; Kuo, HT; Lo, CC; Tseng, KC; Huang, YH; Tai, CM; Peng, CY; Bair, MJ; Chen, CH; Yeh, ML; Lin, CL; Lin, CY; Lee, PL; Chong, LW; Hung, CH; Chang, T; Huang, JF; Yang, CC; Hu, JT; Lin, CW; Wang, CC; Su, WW; Hsieh, TY; Lin, CL; Tsai, WL; Lee, TH; Chen, GY; Wang, SJ; Chang, CC; Yang, SS; Wu, WC; Huang, CS; Chou, KH; Kao, CN; Tsai, PC; Liu, CH; Lee, MH; Cheng, CY; Tsai, MC; Liu, CJ; Dai, CY; Lin, HC; Kao, JH; Chuang, WL; Yu, ML |
| 中山醫學大學 |
2020 |
The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma
|
Lee, SW; Lee, TY; Peng, YC; Yang, SS; Yeh, HZ; Chang, CS |
| 中山醫學大學 |
2020 |
Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment
|
Liu, CH; Yang, SS; Peng, CY; Lin, WT; Liu, CJ; Su, TH; Tseng, TC; Chen, PJ; Chen, DS; Kao, JH |
| 中山醫學大學 |
2020 |
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy
|
Chang, WY; Chiu, YC; Chiu, FW; Hsu, YC; Tseng, TC; Cheng, PN; Yang, SS; Liu, CJ; Su, TH; Yang, HC; Liu, CH; Chen, PJ; Chen, DS; Kao, JH |
| 中山醫學大學 |
2020 |
Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction?
|
Hsu, SJ; Yang, SS; Kao, JH |
Showing items 11-20 of 68 (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page
|
